TheEdgeResearch
Home / Stocks / BQST

BioQuest Corp. (BQST)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.07 ▲ +0.00%
Market Cap
$2.0M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
9.57
52-Wk Range
0.066-1
CEO
Trent T. Daniel
Country
US
Currency
USD

BioQuest Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Katy, TX, US. The stock last traded at $0.07, up 0.00% on the session, giving a market capitalisation of $2.0M. On trailing twelve-month figures it carries a trailing P/E of -2.18, a net margin of -506.9%. Its beta of 9.57 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-2.18
Price / Sales
11.05
Price / Book
-1.79
EV / EBITDA
-2.83
Gross margin
38.7%
Operating margin
-469.3%
Net margin
-506.9%
Return on equity
Debt / equity
-0.35
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
4
IPO date
2014-02-27
Headquarters
Katy, TX, US
About BioQuest Corp.

BioQuest Corp. develops and offers AI-powered voice and chat solutions to help organizations automate communication, enhance engagement, and reduce operational costs. It serves a range of industries, including nonprofits and ministries. The company is based in Katy, Texas.

Comparable companies

BioQuest Corp. is most often compared with the following Healthcare names:

CHHEECGSEGRXHMTXFLUFFFMCUJFOASMYPAXHTRUFFVPHIF
More research on BQST
BQST technical analysis BQST TheEdge Score Compare against peers
Open full interactive analysis & DCF →